🇺🇸 FDA
Pipeline program

Immunohistochemistry or genetic test

LRR202404

Unknown other active

Quick answer

Immunohistochemistry or genetic test for Glioma is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Glioma
Phase
Unknown
Modality
other
Status
active

Clinical trials